Skip to main content

Halozyme Therapeutic (NQ: HALO )

49.06 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Dec 10, 2024 Add to My Watchlist

Other Filings

Form NT 10-K
Source: SEC/Edgar
September 29, 2003
Form 10QSB
Source: SEC/Edgar
August 13, 2003
Form DEF 14C
Source: SEC/Edgar
August 11, 2003
Form PRER14C
Source: SEC/Edgar
July 30, 2003
Form PRE 14C
Source: SEC/Edgar
July 13, 2003
Form SC 13G
Source: SEC/Edgar
June 02, 2003
Form SC 13G
Source: SEC/Edgar
June 01, 2003
Form 10QSB
Source: SEC/Edgar
May 19, 2003
Form 10QSB
Source: SEC/Edgar
May 18, 2003
Form NT 10-Q
Source: SEC/Edgar
May 15, 2003
Form NT 10-Q
Source: SEC/Edgar
May 15, 2003
Form 10KSB/A
Source: SEC/Edgar
May 01, 2003
Form 10KSB
Source: SEC/Edgar
March 30, 2003
Form 8-K/A
Source: SEC/Edgar
March 17, 2003
Form SC 13G
Source: SEC/Edgar
February 19, 2003
Form 10QSB
Source: SEC/Edgar
February 13, 2003
Form SC 13G
Source: SEC/Edgar
February 13, 2003
Form 8-K
Source: SEC/Edgar
January 26, 2003
Form 10QSB
Source: SEC/Edgar
November 13, 2002
Form 10QSB
Source: SEC/Edgar
November 13, 2002
Form 8-K
Source: SEC/Edgar
November 11, 2002
Form 10KSB
Source: SEC/Edgar
October 06, 2002
Form NT 10-K
Source: SEC/Edgar
September 29, 2002
Form 8-K
Source: SEC/Edgar
September 02, 2002
Form 10QSB
Source: SEC/Edgar
August 18, 2002
Form NT 10-Q
Source: SEC/Edgar
August 13, 2002
Form 8-K/A
Source: SEC/Edgar
August 06, 2002
Form 8-K
Source: SEC/Edgar
June 09, 2002
Form SC 13G
Source: SEC/Edgar
June 09, 2002
Form SC 13G
Source: SEC/Edgar
June 09, 2002
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.